TABLE III.

Patient information

Pt id	Age	Sex	Presenting history	Management	Survival (months)
1	64	Female	Lower urinary tract symptoms, flank pain, 4.5-kg weight loss, 30 pack–year smoking history	Cytoreductive nephrectomy; unfit for chemotherapy	33
2	61	Male	Gross hematuria and flank pain, nonsmoker	Initial nephrectomy aborted because of lymphadenopathy; unresponsive to 4 cycles of mvac followed by cytoreductive nephrectomy	11
3	65	Female	Gross hematuria, 40 pack–year smoking history	Unresponsive to 3 cycles of mvac	19
4	70	Male	Declining performance status, weight loss	Performance status too low for chemotherapy	Lost to follow-up
5	69	Male	Not available	Cytoreductive nephrectomy	11
6	72	Male	Lower urinary tract symptoms, no hematuria or flank pain, smoking history	Cytoreductive (partial) nephrectomy (horseshoe kidney)	10

Pt = patient; mvac = methotrexate–vinblastine–doxorubicin–cisplatin chemotherapy.